Click here to get full coverage on FDA Grants Fast Track Designation to GLSI-100 in HLA-A*02+, HER2+ Breast Cancer - OncLive

FDA Grants Fast Track Designation to GLSI-100 in HLA-A*02+, HER2+ Breast Cancer  OncLive

FDA Grants Fast Track Designation to GLSI-100 in HLA-A*02+, HER2+ Breast Cancer - OncLive

Click here to get full coverage on GLSI-100 Gets FDA Fast Track Designation for Breast Cancer - Targeted Oncology

GLSI-100 Gets FDA Fast Track Designation for Breast Cancer  Targeted Oncology

GLSI-100 Gets FDA Fast Track Designation for Breast Cancer - Targeted Oncology

Click here to get full coverage on FDA Fast Tracks GLSI-100 for HER2-Positive Breast Cancer Recurrence Prevention - Oncodaily

FDA Fast Tracks GLSI-100 for HER2-Positive Breast Cancer Recurrence Prevention  Oncodaily

FDA Fast Tracks GLSI-100 for HER2-Positive Breast Cancer Recurrence Prevention - Oncodaily

Click here to get full coverage on GLSI-100 Granted Fast Track Designation for HER2-Positive Breast Cancer - Pharmacy Times

GLSI-100 Granted Fast Track Designation for HER2-Positive Breast Cancer  Pharmacy Times

GLSI-100 Granted Fast Track Designation for HER2-Positive Breast Cancer - Pharmacy Times

Click here to get full coverage on $GLSI stock is up 17% today. Here's what we see in our data. - Quiver Quantitative

$GLSI stock is up 17% today. Here's what we see in our data.  Quiver Quantitative

$GLSI stock is up 17% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Insiders of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) must be frustrated after market cap dropped US$50m since recent purchases - Yahoo Finance

Insiders of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) must be frustrated after market cap dropped US$50m since recent purchases  Yahoo Finance

Insiders of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) must be frustrated after market cap dropped US$50m since recent purchases - Yahoo Finance

Click here to get full coverage on Biotech Greenwich LifeSciences raises $7M in 3 weeks for breast cancer trial - Stock Titan

Biotech Greenwich LifeSciences raises $7M in 3 weeks for breast cancer trial  Stock Titan

Biotech Greenwich LifeSciences raises $7M in 3 weeks for breast cancer trial - Stock Titan

Click here to get full coverage on Why Is GLSI Stock Rising Today? - Stocktwits

Why Is GLSI Stock Rising Today?  Stocktwits

Why Is GLSI Stock Rising Today? - Stocktwits

Click here to get full coverage on A US$74m drop in the market cap of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is not what insiders like to see after purchasing shares recently - simplywall.st

A US$74m drop in the market cap of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is not what insiders like to see after purchasing shares recently  simplywall.st

A US$74m drop in the market cap of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is not what insiders like to see after purchasing shares recently - simplywall.st

Click here to get full coverage on Morning Market Movers: IOTR, SXTP, GLSI, RAYA See Big Swings - RTTNews

Morning Market Movers: IOTR, SXTP, GLSI, RAYA See Big Swings  RTTNews

Morning Market Movers: IOTR, SXTP, GLSI, RAYA See Big Swings - RTTNews

Click here to get full coverage on Greenwich LifeSciences’ GLSI-100 Receives FDA Fast Track Designation for Preventing Breast Cancer Recurrence - Oncodaily

Greenwich LifeSciences’ GLSI-100 Receives FDA Fast Track Designation for Preventing Breast Cancer Recurrence  Oncodaily

Greenwich LifeSciences’ GLSI-100 Receives FDA Fast Track Designation for Preventing Breast Cancer Recurrence - Oncodaily

Click here to get full coverage on $GLSI stock is down 11% today. Here's what we see in our data. - Quiver Quantitative

$GLSI stock is down 11% today. Here's what we see in our data.  Quiver Quantitative

$GLSI stock is down 11% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Biotech locks insiders out of selling stock for six years to back cancer trial - Stock Titan

Biotech locks insiders out of selling stock for six years to back cancer trial  Stock Titan

Biotech locks insiders out of selling stock for six years to back cancer trial - Stock Titan

Click here to get full coverage on Why Did GLSI Stock Surge 25% Today? - Stocktwits

Why Did GLSI Stock Surge 25% Today?  Stocktwits

Why Did GLSI Stock Surge 25% Today? - Stocktwits

Click here to get full coverage on Insider Purchase: CEO and CFO of $GLSI Buys 2,300 Shares - Quiver Quantitative

Insider Purchase: CEO and CFO of $GLSI Buys 2,300 Shares  Quiver Quantitative

Insider Purchase: CEO and CFO of $GLSI Buys 2,300 Shares - Quiver Quantitative

Click here to get full coverage on Greenwich LifeSciences (Nasdaq: GLSI) finishes 250-patient arm, targets 88,000 eligible - Stock Titan

Greenwich LifeSciences (Nasdaq: GLSI) finishes 250-patient arm, targets 88,000 eligible  Stock Titan

Greenwich LifeSciences (Nasdaq: GLSI) finishes 250-patient arm, targets 88,000 eligible - Stock Titan

Click here to get full coverage on FDA approves first GP2 batch for breast cancer trial, 200,000 doses - Stock Titan

FDA approves first GP2 batch for breast cancer trial, 200,000 doses  Stock Titan

FDA approves first GP2 batch for breast cancer trial, 200,000 doses - Stock Titan

Click here to get full coverage on Greenwich LifeSciences, Inc. Announces Acceptance of Two Abstracts for Presentation at AACR Annual Meeting 2026 on Breast Cancer Immunotherapy GLSI-100 - Quiver Quantitative

Greenwich LifeSciences, Inc. Announces Acceptance of Two Abstracts for Presentation at AACR Annual Meeting 2026 on Breast Cancer Immunotherapy GLSI-100  Quiver Quantitative

Greenwich LifeSciences, Inc. Announces Acceptance of Two Abstracts for Presentation at AACR Annual Meeting 2026 on Breast Cancer Immunotherapy GLSI-100 - Quiver Quantitative

Click here to get full coverage on Greenwich LifeSciences Reports 33% Increase in Patient Screening Rate for FLAMINGO-01 Phase III Trial - Quiver Quantitative

Greenwich LifeSciences Reports 33% Increase in Patient Screening Rate for FLAMINGO-01 Phase III Trial  Quiver Quantitative

Greenwich LifeSciences Reports 33% Increase in Patient Screening Rate for FLAMINGO-01 Phase III Trial - Quiver Quantitative

Click here to get full coverage on Greenwich LifeSciences (Nasdaq: GLSI) sees ~80% recurrence cut in 250-patient FLAMINGO-01 arm - Stock Titan

Greenwich LifeSciences (Nasdaq: GLSI) sees ~80% recurrence cut in 250-patient FLAMINGO-01 arm  Stock Titan

Greenwich LifeSciences (Nasdaq: GLSI) sees ~80% recurrence cut in 250-patient FLAMINGO-01 arm - Stock Titan

Click here to get full coverage on Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation - GlobeNewswire

Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation  GlobeNewswire

Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation - GlobeNewswire

Click here to get full coverage on Greenwich LifeSciences, Inc. Announces Extension of Lock-Up Period for Shares to September 30, 2026 - Quiver Quantitative

Greenwich LifeSciences, Inc. Announces Extension of Lock-Up Period for Shares to September 30, 2026  Quiver Quantitative

Greenwich LifeSciences, Inc. Announces Extension of Lock-Up Period for Shares to September 30, 2026 - Quiver Quantitative

Click here to get full coverage on Snehal Patel Buys Handful Of Shares In Greenwich LifeSciences - simplywall.st

Snehal Patel Buys Handful Of Shares In Greenwich LifeSciences  simplywall.st

Snehal Patel Buys Handful Of Shares In Greenwich LifeSciences - simplywall.st

Click here to get full coverage on Patel, Greenwich Lifesciences CEO, buys $63k in GLSI stock - Investing.com

Patel, Greenwich Lifesciences CEO, buys $63k in GLSI stock  Investing.com

Patel, Greenwich Lifesciences CEO, buys $63k in GLSI stock - Investing.com

Click here to get full coverage on FDA Fast Tracks Vaccine For Some With Breast Cancer - CUREtoday.com

FDA Fast Tracks Vaccine For Some With Breast Cancer  CUREtoday.com

FDA Fast Tracks Vaccine For Some With Breast Cancer - CUREtoday.com

Click here to get full coverage on Why did Greenwich LifeSciences stock soar pre-market today? - MSN

Why did Greenwich LifeSciences stock soar pre-market today?  MSN

Why did Greenwich LifeSciences stock soar pre-market today? - MSN

Click here to get full coverage on Greenwich LifeSciences receives approval for FLAMINGO-01 trial in Ireland - Clinical Trials Arena

Greenwich LifeSciences receives approval for FLAMINGO-01 trial in Ireland  Clinical Trials Arena

Greenwich LifeSciences receives approval for FLAMINGO-01 trial in Ireland - Clinical Trials Arena

Click here to get full coverage on GLSI Stock Surges Pre-Market On Clearing FDA Manufacturing Step For Its Breast Cancer Trial - Stocktwits

GLSI Stock Surges Pre-Market On Clearing FDA Manufacturing Step For Its Breast Cancer Trial  Stocktwits

GLSI Stock Surges Pre-Market On Clearing FDA Manufacturing Step For Its Breast Cancer Trial - Stocktwits

Click here to get full coverage on Greenwich gets FDA nod for commercially made product candidate - Seeking Alpha

Greenwich gets FDA nod for commercially made product candidate  Seeking Alpha

Greenwich gets FDA nod for commercially made product candidate - Seeking Alpha

Click here to get full coverage on Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01 - GlobeNewswire

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01  GlobeNewswire

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01 - GlobeNewswire

Click here to get full coverage on Owning 53% in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) means that insiders are heavily invested in the company's future - Yahoo Finance

Owning 53% in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) means that insiders are heavily invested in the company's future  Yahoo Finance

Owning 53% in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) means that insiders are heavily invested in the company's future - Yahoo Finance

Click here to get full coverage on Insider Stock Purchases: January 15, 2026 - Quiver Quantitative

Insider Stock Purchases: January 15, 2026  Quiver Quantitative

Insider Stock Purchases: January 15, 2026 - Quiver Quantitative

Click here to get full coverage on Greenwich LifeSciences CEO Patel buys $53,694 in GLSI stock - Investing.com

Greenwich LifeSciences CEO Patel buys $53,694 in GLSI stock  Investing.com

Greenwich LifeSciences CEO Patel buys $53,694 in GLSI stock - Investing.com

Click here to get full coverage on Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 - GlobeNewswire

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01  GlobeNewswire

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 - GlobeNewswire

Click here to get full coverage on FDA approves commercial GP2 lot for Greenwich’s breast cancer trial - Investing.com

FDA approves commercial GP2 lot for Greenwich’s breast cancer trial  Investing.com

FDA approves commercial GP2 lot for Greenwich’s breast cancer trial - Investing.com

Click here to get full coverage on What's Going On With Greenwich LifeSciences Stock Monday? - Benzinga

What's Going On With Greenwich LifeSciences Stock Monday?  Benzinga

What's Going On With Greenwich LifeSciences Stock Monday? - Benzinga

Click here to get full coverage on Greenwich LifeSciences stock soars after extending insider lock-up - Investing.com

Greenwich LifeSciences stock soars after extending insider lock-up  Investing.com

Greenwich LifeSciences stock soars after extending insider lock-up - Investing.com

Click here to get full coverage on Greenwich LifeSciences stock soars after FDA approves commercial GP2 in trial - Investing.com

Greenwich LifeSciences stock soars after FDA approves commercial GP2 in trial  Investing.com

Greenwich LifeSciences stock soars after FDA approves commercial GP2 in trial - Investing.com

Click here to get full coverage on Greenwich: GP2 Vaccine Milestone - What FDA Manufacturing Approval Means For Investors - Seeking Alpha

Greenwich: GP2 Vaccine Milestone - What FDA Manufacturing Approval Means For Investors  Seeking Alpha

Greenwich: GP2 Vaccine Milestone - What FDA Manufacturing Approval Means For Investors - Seeking Alpha

Click here to get full coverage on Greenwich announces 80% recurrence rate reduction in FLAMINGO-01 arm - MSN

Greenwich announces 80% recurrence rate reduction in FLAMINGO-01 arm  MSN

Greenwich announces 80% recurrence rate reduction in FLAMINGO-01 arm - MSN

Click here to get full coverage on Greenwich LifeSciences stock soars after promising cancer trial results - Investing.com

Greenwich LifeSciences stock soars after promising cancer trial results  Investing.com

Greenwich LifeSciences stock soars after promising cancer trial results - Investing.com

Click here to get full coverage on Greenwich LifeSciences CEO Patel buys $79,866 in GLSI stock - Investing.com

Greenwich LifeSciences CEO Patel buys $79,866 in GLSI stock  Investing.com

Greenwich LifeSciences CEO Patel buys $79,866 in GLSI stock - Investing.com

Click here to get full coverage on Why Is Greenwich LifeSciences Stock Surging After Data From Breast Cancer Vaccine? - Benzinga

Why Is Greenwich LifeSciences Stock Surging After Data From Breast Cancer Vaccine?  Benzinga

Why Is Greenwich LifeSciences Stock Surging After Data From Breast Cancer Vaccine? - Benzinga

Click here to get full coverage on Greenwich LifeSciences Takes Flight As FLAMINGO 01 Breast Cancer Trial Progresses - Nasdaq

Greenwich LifeSciences Takes Flight As FLAMINGO 01 Breast Cancer Trial Progresses  Nasdaq

Greenwich LifeSciences Takes Flight As FLAMINGO 01 Breast Cancer Trial Progresses - Nasdaq

Click here to get full coverage on Greenwich LifeSciences provides updates on Phase III breast cancer trial - Investing.com

Greenwich LifeSciences provides updates on Phase III breast cancer trial  Investing.com

Greenwich LifeSciences provides updates on Phase III breast cancer trial - Investing.com

Click here to get full coverage on Greenwich LifeSciences: Fast Track Designation Does Not Solve Fundamental Issues - Seeking Alpha

Greenwich LifeSciences: Fast Track Designation Does Not Solve Fundamental Issues  Seeking Alpha

Greenwich LifeSciences: Fast Track Designation Does Not Solve Fundamental Issues - Seeking Alpha

Click here to get full coverage on Greenwich LifeSciences abstracts accepted at AACR 2026 meeting - Investing.com

Greenwich LifeSciences abstracts accepted at AACR 2026 meeting  Investing.com

Greenwich LifeSciences abstracts accepted at AACR 2026 meeting - Investing.com

Click here to get full coverage on Top Executive Makes Bold Insider Move on Greenwich LifeSciences Stock - TipRanks

Top Executive Makes Bold Insider Move on Greenwich LifeSciences Stock  TipRanks

Top Executive Makes Bold Insider Move on Greenwich LifeSciences Stock - TipRanks

Click here to get full coverage on Greenwich LifeSciences: What The Recent Data Do For The Investment Thesis (GLSI) - Seeking Alpha

Greenwich LifeSciences: What The Recent Data Do For The Investment Thesis (GLSI)  Seeking Alpha

Greenwich LifeSciences: What The Recent Data Do For The Investment Thesis (GLSI) - Seeking Alpha

Click here to get full coverage on Greenwich LifeSciences shares jump on early breast cancer trial readout - MSN

Greenwich LifeSciences shares jump on early breast cancer trial readout  MSN

Greenwich LifeSciences shares jump on early breast cancer trial readout - MSN

Click here to get full coverage on Greenwich Lifesciences Provides Update On Flamingo-01 Cash Burn Rate And Financing Strategy - TradingView

Greenwich Lifesciences Provides Update On Flamingo-01 Cash Burn Rate And Financing Strategy  TradingView

Greenwich Lifesciences Provides Update On Flamingo-01 Cash Burn Rate And Financing Strategy - TradingView

Click here to get full coverage on Greenwich LifeSciences completes enrollment in Phase III trial arm - Investing.com

Greenwich LifeSciences completes enrollment in Phase III trial arm  Investing.com

Greenwich LifeSciences completes enrollment in Phase III trial arm - Investing.com

Click here to get full coverage on Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial - CUREtoday.com

Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial  CUREtoday.com

Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial - CUREtoday.com

Click here to get full coverage on Greenwich LifeSciences reports 33% rise in trial screening rate - Investing.com Nigeria

Greenwich LifeSciences reports 33% rise in trial screening rate  Investing.com Nigeria

Greenwich LifeSciences reports 33% rise in trial screening rate - Investing.com Nigeria

Click here to get full coverage on Greenwich LifeSciences extends insider share lock-up to Sept 2026 - Investing.com

Greenwich LifeSciences extends insider share lock-up to Sept 2026  Investing.com

Greenwich LifeSciences extends insider share lock-up to Sept 2026 - Investing.com

Click here to get full coverage on Greenwich LifeSciences reports 33% rise in trial screening rate By Investing.com - Investing.com Canada

Greenwich LifeSciences reports 33% rise in trial screening rate By Investing.com  Investing.com Canada

Greenwich LifeSciences reports 33% rise in trial screening rate By Investing.com - Investing.com Canada

Click here to get full coverage on Greenwich LifeSciences reports $12.5 million cash balance - Investing.com

Greenwich LifeSciences reports $12.5 million cash balance  Investing.com

Greenwich LifeSciences reports $12.5 million cash balance - Investing.com

Click here to get full coverage on Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01 - GlobeNewswire

Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01  GlobeNewswire

Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01 - GlobeNewswire

Click here to get full coverage on Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy - GlobeNewswire

Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy  GlobeNewswire

Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy - GlobeNewswire

Click here to get full coverage on Greenwich LifeSciences abstracts accepted at AACR 2026 meeting By Investing.com - Investing.com Canada

Greenwich LifeSciences abstracts accepted at AACR 2026 meeting By Investing.com  Investing.com Canada

Greenwich LifeSciences abstracts accepted at AACR 2026 meeting By Investing.com - Investing.com Canada

Click here to get full coverage on Insider Buying: Snehal Patel Acquires Additional Shares of Green - GuruFocus

Insider Buying: Snehal Patel Acquires Additional Shares of Green  GuruFocus

Insider Buying: Snehal Patel Acquires Additional Shares of Green - GuruFocus

Click here to get full coverage on The Ongoing Investigation of GLSI-100 Continues in the Flamingo-01 Study for HER2/Neu+ Breast Cancer - OncLive

The Ongoing Investigation of GLSI-100 Continues in the Flamingo-01 Study for HER2/Neu+ Breast Cancer  OncLive

The Ongoing Investigation of GLSI-100 Continues in the Flamingo-01 Study for HER2/Neu+ Breast Cancer - OncLive

Click here to get full coverage on Several Insiders Invested In Greenwich LifeSciences Flagging Positive News - Yahoo Finance

Several Insiders Invested In Greenwich LifeSciences Flagging Positive News  Yahoo Finance

Several Insiders Invested In Greenwich LifeSciences Flagging Positive News - Yahoo Finance

Click here to get full coverage on Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date - Yahoo Finance

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date  Yahoo Finance

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date - Yahoo Finance

Click here to get full coverage on GLSI Forecast — Price Prediction for 2026. Should I Buy GLSI? - Intellectia AI

GLSI Forecast — Price Prediction for 2026. Should I Buy GLSI?  Intellectia AI

GLSI Forecast — Price Prediction for 2026. Should I Buy GLSI? - Intellectia AI

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland - Yahoo Finance

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland  Yahoo Finance

GLSI

Price Chart

Key Statistics

Technicals

About GLSI

Latest News

FDA Grants Fast Track Designation to GLSI-100 in HLA-A*02+, HER2+ Breast Cancer - OncLive

GLSI-100 Gets FDA Fast Track Designation for Breast Cancer - Targeted Oncology

FDA Fast Tracks GLSI-100 for HER2-Positive Breast Cancer Recurrence Prevention - Oncodaily

Advanced Charts

Top Gainers

Top Losers